Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets
出版年份 2013 全文链接
标题
Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 12, Issue 4, Pages 365-378
出版商
Informa UK Limited
发表日期
2013-04-06
DOI
10.1586/erv.13.11
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adenovirus Vector-Induced Innate Inflammatory Mediators, MAPK Signaling, As Well As Adaptive Immune Responses Are Dependent upon Both TLR2 and TLR9 In Vivo
- (2014) D. M. Appledorn et al. JOURNAL OF IMMUNOLOGY
- Correction: PfRH5: A Novel Reticulocyte-Binding Family Homolog of Plasmodium falciparum that Binds to the Erythrocyte, and an Investigation of Its Receptor
- (2014) Marilis Rodriguez et al. PLoS One
- Autophagy and the Immune System
- (2012) Petric Kuballa et al. Annual Review of Immunology
- HIV vaccine design: the neutralizing antibody conundrum
- (2012) Leonidas Stamatatos CURRENT OPINION IN IMMUNOLOGY
- Adjuvants for human vaccines
- (2012) Carl R Alving et al. CURRENT OPINION IN IMMUNOLOGY
- Improved outlook on HIV-1 prevention and vaccine development
- (2012) Sandhya Vasan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Recombinant Viral-Vectored Vaccines Expressing Plasmodium chabaudi AS Apical Membrane Antigen 1: Mechanisms of Vaccine-Induced Blood-Stage Protection
- (2012) S. Biswas et al. JOURNAL OF IMMUNOLOGY
- Type I IFN Induced by Adenovirus Serotypes 28 and 35 Has Multiple Effects on T Cell Immunogenicity
- (2012) M. J. Johnson et al. JOURNAL OF IMMUNOLOGY
- Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
- (2012) A. Duerr et al. JOURNAL OF INFECTIOUS DISEASES
- Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection
- (2012) Hongbing Yang et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector
- (2012) Geraldine A. O’Hara et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
- (2012) Dan H. Barouch et al. NATURE
- B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
- (2012) Barton F Haynes et al. NATURE BIOTECHNOLOGY
- Lessons learned from HIV-1 vaccine trials: new priorities and directions
- (2012) Andrew J McMichael et al. NATURE IMMUNOLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- High Affinity Antibodies to Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Malaria
- (2012) Sreenivasulu B. Reddy et al. PLoS One
- Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
- (2012) Susanne H. Sheehy et al. PLoS One
- Expression and Cellular Immunogenicity of a Transgenic Antigen Driven by Endogenous Poxviral Early Promoters at Their Authentic Loci in MVA
- (2012) Toritse Orubu et al. PLoS One
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein
- (2012) Emily K. Forbes et al. PLoS One
- A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
- (2012) Michael C. Keefer et al. PLoS One
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
- (2012) J. J. Moon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
- (2012) S. Colloca et al. Science Translational Medicine
- Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
- (2012) E. Barnes et al. Science Translational Medicine
- Malaria vaccines: Focus on adenovirus based vectors
- (2012) Nathaniel J. Schuldt et al. VACCINE
- Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens
- (2012) Andrew R. Williams et al. PLoS Pathogens
- Long-Term Humoral and Cellular Immune Responses Elicited by a Heterologous Plasmodium vivax Apical Membrane Antigen 1 Protein Prime/Adenovirus Boost Immunization Protocol
- (2011) Leoneide Érica Maduro Bouillet et al. INFECTION AND IMMUNITY
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
- (2011) Jens Wrammert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum
- (2011) Shan Zong et al. JOURNAL OF GENE MEDICINE
- The Requirement for Potent Adjuvants To Enhance the Immunogenicity and Protective Efficacy of Protein Vaccines Can Be Overcome by Prior Immunization with a Recombinant Adenovirus
- (2011) S. C. de Cassan et al. JOURNAL OF IMMUNOLOGY
- CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria
- (2011) A. Reyes-Sandoval et al. JOURNAL OF IMMUNOLOGY
- Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine
- (2011) Lilin Lai et al. JOURNAL OF INFECTIOUS DISEASES
- Differential Effects of Viral Vectors on Migratory Afferent Lymph Dendritic Cells In Vitro Predict Enhanced Immunogenicity In Vivo
- (2011) C. Cubillos-Zapata et al. JOURNAL OF VIROLOGY
- The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
- (2011) E. S. Gray et al. JOURNAL OF VIROLOGY
- Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
- (2011) Susanne H Sheehy et al. MOLECULAR THERAPY
- Antibody-based protection against HIV infection by vectored immunoprophylaxis
- (2011) Alejandro B. Balazs et al. NATURE
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- A Field Trial to Assess a Blood-Stage Malaria Vaccine
- (2011) Mahamadou A. Thera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccines against malaria
- (2011) A. V. S. Hill PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1
- (2011) Sumi Biswas et al. PLoS One
- Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial
- (2011) Beryl A. Koblin et al. PLoS One
- A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
- (2011) Gavin J. Churchyard et al. PLoS One
- A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity
- (2011) Anna L. Goodman et al. PLoS One
- Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
- (2011) Martha Sedegah et al. PLoS One
- Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
- (2011) Cindy Tamminga et al. PLoS One
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
- (2011) X. Wu et al. SCIENCE
- Antibody Repertoire: Embracing Diversity
- (2011) A. J. Pollard et al. Science Translational Medicine
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
- (2011) N. L. Letvin et al. Science Translational Medicine
- Targeting TLRs Expands the Antibody Repertoire in Response to a Malaria Vaccine
- (2011) S. R. Wiley et al. Science Translational Medicine
- Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice
- (2011) Christopher Palma et al. VACCINE
- The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody
- (2011) Alexander D. Douglas et al. Nature Communications
- Blood-stage malaria vaccines — recent progress and future challenges
- (2010) A. L. Goodman et al. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
- The Th1 Immune Response to Plasmodium falciparum Circumsporozoite Protein Is Boosted by Adenovirus Vectors 35 and 26 with a Homologous Insert
- (2010) K. Radosevic et al. Clinical and Vaccine Immunology
- Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
- (2010) Robert M Paris et al. Expert Review of Vaccines
- Prime-boost vectored malaria vaccines: Progress and prospects
- (2010) Adrian V. S. Hill et al. Human vaccines & immunotherapeutics
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- New Candidate Vaccines against Blood-Stage Plasmodium falciparum Malaria: Prime-Boost Immunization Regimens Incorporating Human and Simian Adenoviral Vectors and Poxviral Vectors Expressing an Optimized Antigen Based on Merozoite Surface Protein 1
- (2010) A. L. Goodman et al. INFECTION AND IMMUNITY
- Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines
- (2010) S. J. Draper et al. JOURNAL OF IMMUNOLOGY
- Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine Vectors
- (2010) E. G. Rhee et al. JOURNAL OF VIROLOGY
- Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
- (2010) Richard A. Koup et al. PLoS One
- Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
- (2010) Walter Jaoko et al. PLoS One
- Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant
- (2010) X. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic immunization in the lung induces potent local and systemic immune responses
- (2010) K. Song et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rabies vaccines: WHO position paper—Recommendations
- (2010) VACCINE
- Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth
- (2010) Joseph T. Bruder et al. VACCINE
- The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species
- (2010) Lediya Cheru et al. VACCINE
- Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults
- (2010) Mark A. Pierce et al. VACCINE
- Tailoring subunit vaccine immunogenicity: Maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1
- (2010) Alexander D. Douglas et al. VACCINE
- Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites
- (2010) Nathan W. Schmidt et al. PLoS Pathogens
- Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria
- (2009) Simon J. Draper et al. Cell Host & Microbe
- Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay
- (2009) K. Miura et al. Clinical and Vaccine Immunology
- Innate Immune Recognition of Viruses and Viral Vectors
- (2009) Xiaopei Huang et al. HUMAN GENE THERAPY
- Mapping Epitopes of the Plasmodium vivax Duffy Binding Protein with Naturally Acquired Inhibitory Antibodies
- (2009) P. Chootong et al. INFECTION AND IMMUNITY
- Cytokine-secreting follicular T cells shape the antibody repertoire
- (2009) R Lee Reinhardt et al. NATURE IMMUNOLOGY
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
- (2009) Philip R Johnson et al. NATURE MEDICINE
- Viruses as vaccine vectors for infectious diseases and cancer
- (2009) Simon J. Draper et al. NATURE REVIEWS MICROBIOLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
- (2009) Michele D. Spring et al. PLoS One
- High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model
- (2009) Sheetij Dutta et al. PLoS One
- Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection
- (2009) Edward O. Ronan et al. PLoS One
- A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel® with CPG 7909, using two different formulations and dosing intervals
- (2009) Ruth D. Ellis et al. VACCINE
- Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs
- (2009) Constantinos S. Kyriakis et al. VACCINE
- Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
- (2009) M. Dudareva et al. VACCINE
- Poxvirus-vectored vaccines for rabies—A review
- (2009) Jacqueline Weyer et al. VACCINE
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
- (2009) Julie Delaloye et al. PLoS Pathogens
- Kinetics of Recombinant Adenovirus Type 5, Vaccinia Virus, Modified Vaccinia Ankara Virus, and DNA Antigen Expression In Vivo and the Induction of Memory T-Lymphocyte Responses
- (2008) R. Geiben-Lynn et al. Clinical and Vaccine Immunology
- Single-dose immunogenicity and protective efficacy of simian adenoviral vectors againstPlasmodium berghei
- (2008) Arturo Reyes-Sandoval et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Reticulocyte-binding protein homologue 5 – An essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum
- (2008) Jake Baum et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques
- (2008) J. H. C. M. Kreijtz et al. JOURNAL OF INFECTIOUS DISEASES
- Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A
- (2008) S. Sridhar et al. JOURNAL OF VIROLOGY
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
- (2008) Jinyan Liu et al. NATURE
- Effective induction of high-titer antibodies by viral vector vaccines
- (2008) Simon J Draper et al. NATURE MEDICINE
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
- Protection Induced by Plasmodium falciparum MSP142 Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses
- (2008) Jeffrey A. Lyon et al. PLoS One
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
- (2008) Else Marie Agger et al. PLoS One
- Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
- (2008) Meta Roestenberg et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now